Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer
Condition(s):Neoplasms, BreastLast Updated:December 27, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Neoplasms, BreastLast Updated:December 27, 2019Completed
Condition(s):Pneumococcal Infections; Pneumococcal Conjugate VaccineLast Updated:December 20, 2021Unknown status
Condition(s):Neisseria MeningitidisLast Updated:May 21, 2015Completed
Condition(s):Covid-19Last Updated:January 26, 2021Completed
Condition(s):COVID-19; SARS-CoV 2Last Updated:December 2, 2022Completed
Condition(s):Dengue; Dengue Hemorrhagic FeverLast Updated:March 25, 2022Completed
Condition(s):Atopic DermatitisLast Updated:May 9, 2017Completed
Condition(s):Coronavirus InfectionLast Updated:September 17, 2021Unknown status
Condition(s):Diphtheria; Tetanus; Haemophilus Influenzae Type b; Pertussis; PoliomyelitisLast Updated:April 17, 2012Completed
Condition(s):Iron Deficiency AnemiaLast Updated:November 29, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.